$6.4M Awarded in 2025 | The Next Wave of Rett Genetic Medicines
In 2025, RSRT awarded $6.4 million to advance genetic medicines for Rett syndrome, bringing our total investment in Rett cures to $92 million. These awards support both components of genetic medicines: what we deliver and how we deliver it — with the goal of advancing multiple programs toward clinical trials in 2028. Head of Research John Sinnamon shares where the science stands today and what comes next. Explore the full 2025 Awards here: [hub link] Learn more about RSRT’s work to develop genetic medicines for Rett: https://reverserett.org/2025-research... #RettSyndrome #GeneticMedicine #RareDisease #ClinicalTrials
▶︎
Reverse Rett LA Gala 2024 - Event Video
▶︎
Melania Trump's NEW FACE | Plastic Surgery Analysis
▶︎
AI Meets Rett: RSRT funds $1M Collaboration with Profluent to Advance Gene-editing with AI
▶︎
Why The Russian Accent Terrifies Everyone
▶︎
The truth about “tradwives” and the men who want them | 60 Minutes Australia
▶︎
Inside the Fight to Cure Rett Syndrome – Monica Coenraads Interview
▶︎
Why Scammers Stay Silent for 3 Seconds When You Pick Up
▶︎
RSRT + Tacit Therapeutics: RNA Trans-splicing Award
▶︎
25 Years Fighting Rett: Thank You Monica!
▶︎
Truth Behind Anne Hathaway's Look | Plastic Surgeon Reacts
▶︎
Colin Farrell Opens Up About His Son With Angelman Syndrome | PEOPLE
▶︎
ADHD Child vs. Non-ADHD Child Interview
▶︎
The French Do Not Care About Work
▶︎
The Tragedy Behind the American Chopper Cast — Where Are They Now?
▶︎
Rewriting RNA: RSRT Funds Genetic Engineers in the AbuGoot Lab
▶︎
A Message from Tim Freeman: Thank You
▶︎
'Listen Like You Might Be Wrong': Harvard Student Goes Viral For Stunning Speech On Trump Amid Feud
▶︎
Nobody Breaks Celebrities Like Rowan Atkinson
▶︎
The Future of Rett Syndrome: Dr Ram Kumar on emerging therapies
▶︎